Skip to main content
Premium Trial:

Request an Annual Quote

GenoMed Pursues 50 Caucasian Sera Samples to Study Disease Links

NEW YORK, Jan. 21 - GenoMed on Friday said it has signed a Letter of Intent with the DW Coordinating Center to buy 50 Caucasian samples of "common, serious diseases."

DWCC, a global contract-research group with research ties to Eastern Europe based in Los Altos, Calif., will obtain blood samples from patients with "common diseases" like hypertension, myocardial infarction, stroke, and some cancers.

GenoMed, of St. Louis, Mo., said that over the next 1 to 2 years it "will score millions of genotypes" from these samples and try to identify genomic links that connect particular ethnic groups with a certain disease.

Financial terms of the deal were not disclosed.

"I am confident that the [GenoMed's] relationships with organizations such as DWCC will provide the [it] with the samples that it needs to generate a tremendous amount of disease gene data from a variety of ethnic groups," David Moskowitz, chairman and chief medical officer of GenoMed, said in a statement.

Last November, GenoMed, art the time based in Sarasota, Fla., acquired its St. Louis-based subsidiary, Genomic Medicine. Terms of that deal call for the subsidiary to collect a $2 million to $6 million investment over the next year.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.